Related references
Note: Only part of the references are listed.Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2
Yang Suo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2023)
Emerging Roles of the Human Solute Carrier 22 Family
Sook Wah Yee et al.
DRUG METABOLISM AND DISPOSITION (2022)
Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes
Angelika Janaszkiewicz et al.
SCIENTIFIC REPORTS (2022)
Structural basis of organic cation transporter-3 inhibition
Basavraj Khanppnavar et al.
NATURE COMMUNICATIONS (2022)
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Eric F. Pettersen et al.
PROTEIN SCIENCE (2021)
In-depth interrogation of protein thermal unfolding data with MoltenProt
Vadim Kotov et al.
PROTEIN SCIENCE (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Structural basis of antifolate recognition and transport by PCFT
Joanne L. Parker et al.
NATURE (2021)
Systems Biology Analysis Reveals Eight SLC22 Transporter Subgroups, Including OATs, OCTs, and OCTNs
Darcy C. Engelhart et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy
Caiyu Li et al.
TOXICOLOGICAL SCIENCES (2020)
Generation of synthetic nanobodies against delicate proteins
Iwan Zimmermann et al.
NATURE PROTOCOLS (2020)
Probenecid-Boosted Tenofovir: A Physiologically-Based Pharmacokinetic Model-Informed Strategy for On-Demand HIV Preexposure Prophylaxis
Stephanie N. Liu et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia
Kei Nishizawa et al.
PLOS ONE (2019)
Identification of Natural Products as Inhibitors of Human Organic Anion Transporters (OAT1 and OAT3) and Their Protective Effect on Mercury-Induced Toxicity
Xue Wang et al.
TOXICOLOGICAL SCIENCES (2018)
The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease
Sanjay K. Nigam
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective
Avner Schlessinger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Real-space refinement in PHENIX for cryo-EM and crystallography
Pavel V. Afonine et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2018)
New tools for automated high-resolution cryo-EM structure determination in RELION-3
Jasenko Zivanov et al.
ELIFE (2018)
Organic Anion Transporter 2: An Enigmatic Human Solute Carrier
Hong Shen et al.
DRUG METABOLISM AND DISPOSITION (2017)
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Ali Punjani et al.
NATURE METHODS (2017)
Tools for ligand validation in Coot
Paul Emsley
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2017)
Recent advances in understanding proton coupled peptide transport via the POT family
Simon Newstead
CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)
Shared Molecular Mechanisms of Membrane Transporters
David Drew et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
Understanding transport by the major facilitator superfamily (MFS): structures pave the way
Esben M. Quistgaard et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Renal drug transporters and their significance in drug-drug interactions
Jia Yin et al.
ACTA PHARMACEUTICA SINICA B (2016)
Mechanism of high affinity inhibition of the human urate transporter URAT1
Philip K. Tan et al.
SCIENTIFIC REPORTS (2016)
Structural Biology of the Major Facilitator Superfamily Transporters
Nieng Yan
ANNUAL REVIEW OF BIOPHYSICS, VOL 44 (2015)
Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia
G. Andrei et al.
ANTIVIRAL RESEARCH (2015)
SLC transporters as therapeutic targets: emerging opportunities
Lawrence Lin et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Gating Topology of the Proton-Coupled Oligopeptide Symporters
Philip W. Fowler et al.
STRUCTURE (2015)
Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function
Maja Henjakovic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Functional architecture of MFS D-glucose transporters
M. Gregor Madej et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue
Megha A. Nagle et al.
NEUROSCIENCE LETTERS (2013)
Use of anion-aromatic interactions to position the general base in the ketosteroid isomerase active site
Jason P. Schwans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Drug transport by Organic Anion Transporters (OATs)
Gerhard Burckhardt
PHARMACOLOGY & THERAPEUTICS (2012)
Organic Anion Transporters and Their Implications in Pharmacotherapy
Arian Emami Riedmaier et al.
PHARMACOLOGICAL REVIEWS (2012)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Use of In Vivo Animal Models to Assess Pharmacokinetic Drug-Drug Interactions
Cuyue Tang et al.
PHARMACEUTICAL RESEARCH (2010)
electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation
Nigel W. Moriarty et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
The chloride dependence of the human organic anion transporter 1 (hOAT1) is blunted by mutation of a single amino acid
Ahsan N. Rizwan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A three-dimensional model of human organic anion transporter 1 - Aromatic amino acids required for substrate transport
Jennifer L. Perry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Drug-drug interactions involving membrane transporters in the human kidney
Meng Li et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Focused ion beam preparation techniques dedicated for the fabrication of TEM lamellae of fibre-reinforced composites
H Mucha et al.
JOURNAL OF ELECTRON MICROSCOPY (2005)
Role of glycosylation in the organic anion transporter OAT1
K Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules
S Ekaratanawong et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
The SLC22 drug transporter family
H Koepsell et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Organic anion transporting polypeptides of the OATP/SLC21 family:: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties
B Hagenbuch et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Molecular identification of a renal urate-anion exchanger that regulates blood urate levels
A Enomoto et al.
NATURE (2002)
Share Paper
